SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity - Scorecard - MDSpire

SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity

  • By

  • Barbara Pala

  • Mariagrazia Piscione

  • Maria Carmela Di Marcantonio

  • Francesco Cribari

  • Roberta Vitale

  • Thomas Baldi

  • Ada Popolo

  • Gabriella Mincione

  • June 9, 2026

  • 0 min

Share

Clinical Scorecard: Simvastatin as a Potential Strategy for Mitigating Cardiotoxic Effects of Doxorubicin

At a Glance

CategoryDetail
Condition
Key MechanismsRemove unsupported claims about cardioprotection.
Target Population
Care Setting

Key Highlights

  • remove

Guideline-Based Recommendations

Diagnosis

    Management

    • R
    • e
    • m
    • o
    • v
    • e
    • u
    • n
    • s
    • u
    • p
    • p
    • o
    • r
    • t
    • e
    • d
    • r
    • e
    • c
    • o
    • m
    • m
    • e
    • n
    • d
    • a
    • t
    • i
    • o
    • n
    • a
    • b
    • o
    • u
    • t
    • s
    • i
    • m
    • v
    • a
    • s
    • t
    • a
    • t
    • i
    • n
    • t
    • h
    • e
    • r
    • a
    • p
    • y
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Remove unsupported claims about cardioprotection.

        Clinical Best Practices

        • remove

        Related Resources & Content

        Original Source(s)

        SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity

        • by Barbara Pala, Mariagrazia Piscione, Maria Carmela Di Marcantonio, Francesco Cribari, Roberta Vitale, Thomas Baldi, Ada Popolo, Gabriella Mincione

        • June 9, 2026

        Related Content

        Cardiovascular diseases, prevention, and management of complications in older adults and frail patients treated for elective or post-traumatic hip orthopaedic interventions: a clinical consensus statement of the ESC Council for Cardiology Practice (CCP), the European Association of Preventive Cardiology (EAPC), the Association for Acute CardioVascular Care (ACVC), the Association of Cardiovascular Nursing & Allied Professions of the ESC (ACNAP), the ESC Working Group on Aorta and Peripheral Vascular Diseases (WG APVD), and the ESC Working Group on Thrombosis (WG T)

        Fontan haemodynamics in adults with obesity compared with overweight and normal body mass index: a retrospective invasive exercise study

        Effects of exercise training on nitric oxide metabolites in heart failure with reduced or preserved ejection fraction: a secondary analysis of the SMARTEX-HF and OptimEx-Clin trials